Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 72 entries
View as:

A Study Comparing Adapalene Gel 0.1% and to Differin Gel in the Treatment of Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT04797793 Org: User:
Start: 05/18/20 End: 01/08/21 Due: 01/08/22

To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.05% and RLD in the Treatment of Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT03433378 Org: User:
Start: 08/04/17 End: 01/26/18 Due: 01/26/19

To Evaluate the Therapeutic Equivalence and Safety of Azelaic Acid 15% Topical Gel

Phase: N/A Priority: Normal
NCT ID: NCT03094403 Org: User:
Start: 07/01/16 End: 04/01/17 Due: 04/01/18

Study Comparing Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% to Epiduo® and Both to a Placebo Control in the Treatment of Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT01742637 Org: User:
Start: 10/31/12 End: 03/31/14 Due: 03/31/15

A Study Comparing the Efficacy of TA103 and the Placebo Control in the Treatment of Interdigital Tinea Pedis.

Phase: N/A Priority: Normal
NCT ID: NCT04883593 Org: User:
Start: 09/03/20 End: 02/20/21 Due: 02/20/22

Phase III Clinical Study in Patients With Mild to Severe Scalp Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02933866 Org: User:
Start: 03/11/16 End: 09/29/17 Due: 09/29/18

Effects of Desoximetasone Spray 0.25% on Moderate to Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01206387 Org: User:
Start: 08/31/10 End: 01/31/11 Due: 01/31/12

Bio-equivalence Vasoconstriction Activity Study for Topically Applied Clocortolone Pivalate 0.1% Cream

Phase: N/A Priority: Normal
NCT ID: NCT04358770 Org: User:
Start: 03/02/18 End: 05/11/18 Due: 05/11/19

To Evaluate the Therapeutic Equivalence and Safety in Treatment of Scalp Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03880357 Org: User:
Start: 10/22/18 End: 03/15/19 Due: 03/15/20

Bioequivalence Study of Two Imiquimod Cream 5%

Phase: N/A Priority: Normal
NCT ID: NCT00828568 Org: User:
Start: 06/30/08 End: 05/31/09 Due: 05/31/10

Effects of Desoximetasone Spray 0.25% in Patients With Moderate to Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01206660 Org: User:
Start: 08/31/10 End: 01/31/11 Due: 01/31/12

Clinical Study to Evaluate the Bioequivalence of Two Imiquimod Cream 3.75% Formulations in Patients With Actinic Keratosis.

Phase: N/A Priority: Normal
NCT ID: NCT01788007 Org: User:
Start: 01/31/13 End: 12/31/13 Due: 12/31/14

Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical Product

Phase: N/A Priority: Normal
NCT ID: NCT02933502 Org: User:
Start: 07/11/16 End: 01/02/18 Due: 01/02/19

Clinical Equivalence of Two Butenafine Hydrochloride 1% Creams in Patients With Interdigital Tinea Pedis

Phase: N/A Priority: Normal
NCT ID: NCT00835510 Org: User:
Start: 06/30/08 End: 12/31/08 Due: 12/31/09

Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02601469 Org: User:
Start: 09/04/15 End: 08/25/17 Due: 08/25/18

A Study Comparing Trifarotene Cream 0.005% to AKLIEF® CREAM (US REFERENCE LISTED DRUG), AKLIEF™ CREAM (CANADIAN REFERENCE PRODUCT) in the Treatment of Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT06733402 Org: User:
Start: 06/20/24 End: 11/09/24 Due: 11/09/25

A Study Comparing Tretinoin Cream 0.025% and RETIN-A® Cream 0.025% in the Treatment of Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT04724473 Org: User:
Start: 12/10/19 End: 11/21/20 Due: 11/21/21

A Study Comparing Tretinoin Gel Microsphere, 0.1% and RETIN-A MICRO ® Gel Microsphere, 0.1% in the Treatment of Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT04883736 Org: User:
Start: 08/31/20 End: 04/16/21 Due: 04/16/22

An Open Label, Safety Study to Assess the Potential for Adrenal Suppression.

Phase: N/A Priority: Normal
NCT ID: NCT02932891 Org: User:
Start: 08/31/16 End: 12/12/17 Due: 12/12/18

Evaluate the Safety & Bioequivalence of a Generic Butenafine Cream & Lotrimin Ultra® & Compare Both to a Vehicle Control in Treatment of Interdigital Tinea Pedis

Phase: N/A Priority: Normal
NCT ID: NCT01580878 Org: User:
Start: 01/31/12 End: 12/31/12 Due: 12/31/13

A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea

Phase: N/A Priority: Normal
NCT ID: NCT01513863 Org: User:
Start: 08/31/11 End: 09/30/12 Due: 09/30/13

A Study Comparing Trifarotene Cream 0.005% to AKLIEF® Cream in the Treatment of Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT06063473 Org: User:
Start: 02/22/23 End: 07/13/23 Due: 07/13/24

Safety and Efficacy of NVXT Solution in Mild-to-Moderate Fungal Infection of the Toe Nail

Phase: N/A Priority: Normal
NCT ID: NCT02343627 Org: User:
Start: 12/31/14 End: 01/31/16 Due: 01/31/17

Study Comparing Test to Aczone 5% and Both to a Placebo Control in the Treatment of Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT02929719 Org: User:
Start: 04/30/14 End: 06/30/16 Due: 06/30/17

A Study Comparing Oxymetazoline 1% Cream to RHOFADE

Phase: N/A Priority: Normal
NCT ID: NCT05148689 Org: User:
Start: 02/23/18 End: 05/31/19 Due: 05/31/20